References
- Ho M: Epidemiology of cytomegalovirus infections. Rev Infect Dis 12(Suppl 7);S701-S710, 1990 https://doi.org/10.1093/clinids/12.Supplement_7.S701
- Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH: Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72;2059-2064, 1991 https://doi.org/10.1099/0022-1317-72-9-2059
- Minton EJ, Tysoe C, Sinclair JH, Sissons JG: Human cytomegalovirus infection of the monocytes/macrophages lineage in bone marrow. J Virol 68;4017-4021, 1994
- Soderberg-Naucler C, Fish KN, Nelson JA: Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91;119-126, 1997 https://doi.org/10.1016/S0092-8674(01)80014-3
- Mindelson M, Monard S, Sissons P, Sinclair J: Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol 77;3099-3102, 1996 https://doi.org/10.1099/0022-1317-77-12-3099
- Michelson S: Interaction of human cytomegalovirus with monocytes/ macrophages: a love-hate relationship. Pathol Biol (Paris) 45;146-158, 1997
- Meyers JD, Flournoy N, Thomas ED: Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 153;478-488, 1986 https://doi.org/10.1093/infdis/153.3.478
- Meyers JD, Ljungman P, Fisher LD: Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viraemia. J Infect Dis 162;373-380, 1990 https://doi.org/10.1093/infdis/162.2.373
- Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392;245, 1998 https://doi.org/10.1038/32588
- Foster AE, Forrester K, Gottlieb DJ, Barton GW, Romagnoli JA, Bradstock KF: Large-scale expansion of cytomegalovirus- specific cytotoxic T cells in suspension culture. Biotechnol Bioeng 85;138-146, 2004 https://doi.org/10.1002/bit.10801
- Verma IM, Somia N: Gene therapy - promises, problems and prospects. Nature 389;239-242, 1997 https://doi.org/10.1038/38410
- Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevski SA, Dowdy SF: Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 41;449-452, 1998
- Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF: In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285;1569-1572, 1999 https://doi.org/10.1126/science.285.5433.1569
- Pande H, Baak SW, Riggs AD, Clark BR, Shively JE, Zaia JA: Cloning and physical mapping of a gene fragment coding for a 64-kilodalton major late antigen of human cytomegalovirus. Proc Natl Acad Sci USA 81;4965-4969, 1984 https://doi.org/10.1073/pnas.81.15.4965
- Kern F, Bunde T, Faulhaber N, Kiecker F, Khatamzas E, Rudawski IM, Pruss A, Gratama JW, Volkmer-Engert R, Ewert R, Reinke P, Volk HD, Picker LJ: Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J Infect Dis 185;1709-1716, 2002 https://doi.org/10.1086/340637
- Bradford MA: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72;248-254, 1976 https://doi.org/10.1016/0003-2697(76)90527-3
- Gavin MA, Gilbert MJ, Riddell SR, Greenberg PD, Bevan MJ: Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J Immunol 151;3971-3980, 1993
- Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, Plachter B, Sissons JG: The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 70;7569-7579, 1996
- Cho HI, Han H, Kim CC, Kim TG: Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro. J Immunother 24;242-249, 2001 https://doi.org/10.1097/00002371-200105000-00008
- Paston SJ, Dodi IA, Madrigal JA: Progress made towards the development of a CMV peptide vaccine. Human Immunology 65;544-549, 2004 https://doi.org/10.1016/j.humimm.2004.02.005
- Fittipaldi A, Giacca M: Transcellular protein transduction using the Tat protein of HIV-1. Adv Drug Deliv Rev 57; 597-608, 2005 https://doi.org/10.1016/j.addr.2004.10.011
- Wadia JS, Dowdy SF: Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv Drug Deliv Rev 57;579-596, 2005 https://doi.org/10.1016/j.addr.2004.10.005
Cited by
- Expression, purification and characterization of a recombinant Tat47-57-Oct4 fusion protein in Pichia pastoris vol.9, pp.2, 2011, https://doi.org/10.3892/mmr.2013.1857